Oramed Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com
on February 7th
Company invites Main Street and Wall Street investors to attend interactive
real-time virtual conference
NEW YORK, Feb. 5, 2013
NEW YORK, Feb. 5, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (OTC:ORMPD)
(http://www.oramed.com), a developer of oral drug delivery systems, announced
today that Nadav Kidron, Chief Executive Officer & Director, will present at
DATE: February 7, 2013
TIME: 9:15 AM EST
LINK: www.retailinvestorconferences.com > red "register / watch event
This will be a live, interactive online event where investors are invited to
ask the company questions in real-time - both in the presentation hall as well
as the company's "virtual trade booth." If attendees are not able to join the
event live on the day of the conference, an on-demand archive will be
available for 90 days.
It is recommended that investors pre-register to save time and receive event
About Oramed Pharmaceuticals
Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery
solutions for drugs and vaccines currently delivered via injection.
Established in 2006, Oramed's technology is based on over 30 years of research
by top research scientists at Jerusalem's Hadassah Medical Center. Oramed is
seeking to revolutionize the treatment of diabetes through its proprietary
flagship product, an orally ingestible insulin capsule (ORMD-0801) currently
approaching FDA-approved Phase 2 clinical trials, and with its oral exenatide
capsule (ORMD-0901; a GLP-1 analog), currently approaching Phase 1b/2a trials.
The company's corporate and R&D headquarters are based in Jerusalem.
Since 2010, RetailInvestorConferences.com, created by BetterInvesting (NAIC)
PR NewswireandMUNCmedia, has been the only monthly virtual investor
conference series that provides an interactive forum for presenting companies
to meet directly with retail investors using a graphically-enhanced online
Designed to replicate the look and feel of location-based investor
conferences, Retail Investor Conferences unites PR Newswire's leading-edge
online conferencing and investor communications capabilities with
BetterInvesting's extensive retail investor audience network and MUNCmedia's
sophisticated retail investor targeting.
SOURCE Oramed Pharmaceuticals Inc.
Contact: Oramed Pharmaceuticals, Aviva Sherman, email@example.com,
+972-2-566-0001; or RetailInvestorConferences.com, Bradley H. Smith,
Press spacebar to pause and continue. Press esc to stop.